Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

How to Become a T Follicular Helper Cell

03.08.2015

Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design

Follicular helper Tcells (TFH cells), a rare type of immune cell that is essential for inducing a strong and lasting antibody response to viruses and other microbes, have garnered intense interest in recent years but the molecular signals that drive their differentiation had remained unclear. Now, a team of researchers at the La Jolla Institute for Allergy and Immunology has identified a pair of master regulators that control the fate of TFH cells.


Joyce Hu, La Jolla Institute for Allergy and Immunology

Follicular helper T cells (cells with green surface markers) interact closely with B cells (cells with orange surface markers) to facilitate the proliferation of B cells and the production of high affinity antibodies. The interaction site is shown in yellow, DNA in blue. Image: Courtesy of Joyce Hu, La Jolla Institute of Allergy and Immunology.

Their finding, published in this week’s online edition of Nature Immunology, holds great promise for improved vaccine design and may lead to new treatments for immune disorders and possibly even cancer. “Almost all licensed human vaccines work on the basis of inducing a long-term, protective antibody response,” says the study’s lead author Shane Crotty, Ph.D., a professor in the Institute’s Division of Vaccine Discovery. “Being able to enhance or increase the frequency of follicular helper T cells may be an excellent approach for better vaccine design.”

Before B cells can launch a full-blown antibody response against invading pathogens they undergo a tightly orchestrated, multi-step maturation process aided by TFH cells. Often compared to a miniaturized Darwinian struggle for survival, this process selectively promotes the proliferation of B cells that produce high-affinity antibodies and weeds out those that produce less potent ones.

“B cells compete for TFH cells to survive,” explains postdoctoral researcher and first author Youn Soo Choi, Ph.D., “Only those B cells that produce highly specific antibodies attract TFH cells and are able to proliferate.” The survivors undergo successive rounds of mutation and selection resulting in better and better antibodies during the course of an immune response.

“TFH cells are essential for the production of most types of antibodies and defects in TFH function or frequency can have dramatic effects,” says Crotty. “It may be particularly important when antibody targets are difficult to recognize and B cells need to explore a bigger mutational landscape. A better understanding of how these cells are produced could really make a difference in how likely it is that your body manages to make good antibodies against an infection.”

In an earlier study, Crotty’s team had identified the BCL6 gene as a crucial mastermind in the differentiation of TFH cells but important pieces of the puzzles had still been missing. A combination of functional genomics and bioinformatics analysis allowed Choi to narrow the list of potential candidates down to a pair of transcription factors, LEF-1 and TCF-1.

Transcription factors act as master switching by binding to regulatory regions in the genome, where they modulate gene activity. He then confirmed the importance of LEF-1 and TCF-1 for the differentiation of TFH cells with the help of mice genetically engineered to lack the genes encoding either LEF-1 or TCF-1.

“Their activity pre-programs CD4+ T cells to respond to TFH induction signals,” says Choi. “It seems very likely that any perturbation that results in lower levels of these transcription factors could decrease the likelihood that T cells differentiate into TFH cells.”

As a matter of fact, individual differences in the predilection to make more TFH cells could explain why some individuals produce highly efficient antibodies against HIV, while most individuals are unable to mount a potent immune response. “It is very difficult to create high-affinity antibodies for HIV, which are necessary to neutralize virus,” explains Crotty. “Interestingly, it turns out that those individuals that are able to make broadly neutralizing antibodies against HIV, have unusually elevated levels of highly functional memory TFH cells. We speculate that these people may have a genetic bias to produce a really good TFH response but we haven’t identified it yet.”

The research was supported by the La Jolla Institute for Allergy and Immunology, the American Cancer Society (RSG-11-161-01-MPC), and the National Institutes of Health (AI105351, AI112579, AI115149, AI119160, AI113806, AI109976, AI063107 and AI072543).

Full citation: “LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6.” Youn Soo Choi, Jodi A Gullicksrud, Shaojun Xing, Zhouhao Zeng, Qiang Shan, Fengyin Li, Paul E Love, Weiqun Peng, Hai-Hui Xue & Shane Crotty. doi:10.1038/ni.3226

ABOUT LA JOLLA INSTITUTE La Jolla Institute for Allergy and Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading towards its goal: life without disease®.

Contact Information
Gina Kirchweger
Communications Officer
gina@liai.org
Phone: 858-752-6640
Mobile: 858-357-7481

Gina Kirchweger | newswise
Further information:
http://www.liai.org

Further reports about: Allergy B cells Cell HIV Helper Jolla T cells antibody response transcription factors

More articles from Life Sciences:

nachricht Atomic layer 3D printing
28.01.2020 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht The synthesis of bio-based high-performance polyamide from biogenic residues: A real alternative to crude oil
27.01.2020 | Technische Universität München

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Integrate Micro Chips for electronic Skin

Researchers from Dresden and Osaka present the first fully integrated flexible electronics made of magnetic sensors and organic circuits which opens the path towards the development of electronic skin.

Human skin is a fascinating and multifunctional organ with unique properties originating from its flexible and compliant nature. It allows for interfacing with...

Im Focus: Dresden researchers discover resistance mechanism in aggressive cancer

Protease blocks guardian function against uncontrolled cell division

Researchers of the Carl Gustav Carus University Hospital Dresden at the National Center for Tumor Diseases Dresden (NCT/UCC), together with an international...

Im Focus: New roles found for Huntington's disease protein

Crucial role in synapse formation could be new avenue toward treatment

A Duke University research team has identified a new function of a gene called huntingtin, a mutation of which underlies the progressive neurodegenerative...

Im Focus: A new look at 'strange metals'

For years, a new synthesis method has been developed at TU Wien (Vienna) to unlock the secrets of "strange metals". Now a breakthrough has been achieved. The results have been published in "Science".

Superconductors allow electrical current to flow without any resistance - but only below a certain critical temperature. Many materials have to be cooled down...

Im Focus: Programmable nests for cells

KIT researchers develop novel composites of DNA, silica particles, and carbon nanotubes -- Properties can be tailored to various applications

Using DNA, smallest silica particles, and carbon nanotubes, researchers of Karlsruhe Institute of Technology (KIT) developed novel programmable materials....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

„Advanced Battery Power“- Conference, Contributions are welcome!

07.01.2020 | Event News

 
Latest News

The synthesis of bio-based high-performance polyamide from biogenic residues: A real alternative to crude oil

27.01.2020 | Life Sciences

Superfast insights into cellular events

27.01.2020 | Life Sciences

The 'place' of emotions

27.01.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>